Clinical and Personal Utility of Genetic Risk Testing.

AMERICAN FAMILY PHYSICIAN（2018）

引用 24|浏览8

暂无评分

摘要

On April 6, 2017, the U.S. Food and Drug Administration (FDA) approved marketing of the 23andMe Personal Genome Service, the first direct-to-consumer genetic test. This test uses genomic DNA collected from mail-in saliva collection kits to provide information on a patientu0027s genetic risk of certain medical diseases or conditions.

查看译文

关键词

genetic risk testing,personal utility,clinical

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要